XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cash Equivalents and Investments - Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments (Details) - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Cash and Cash Equivalents [Line Items]    
Amortized Cost $ 2,353,469 $ 2,405,617
Unrealized Gain 0 10
Unrealized Loss (38,333) (11,747)
Estimated Fair Value  2,315,136 2,393,880
Cash Equivalents    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 91,598 152,223
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value  91,598 152,223
Cash Equivalents | Money market funds    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 91,598 152,223
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value  91,598 152,223
Short-term Investments    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 2,261,871 2,253,394
Unrealized Gain 0 10
Unrealized Loss (38,333) (11,747)
Estimated Fair Value  2,223,538 2,241,657
Short-term Investments | U.S. treasury securities    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 2,032,380 1,922,344
Unrealized Gain 0 10
Unrealized Loss (34,840) (10,166)
Estimated Fair Value  1,997,540 1,912,188
Short-term Investments | Corporate debt securities    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 229,491 331,050
Unrealized Gain 0 0
Unrealized Loss (3,493) (1,581)
Estimated Fair Value  $ 225,998 $ 329,469